Pfizer’s Epogen/Procrit biosimilar wins US backing
admin 26th May 2017 Uncategorised 0Pfizer’s biosimilar of Amgen’s epoetin alfa (Epogen/Procrit) has won backing in the US for approval across all proposed indications.
More: Pfizer’s Epogen/Procrit biosimilar wins US backing
Source: News